SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001827672-23-000020
Filing Date
2023-03-21
Accepted
2023-03-21 19:01:10
Documents
1
Period of Report
2023-03-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167943965959717.html 4  
1 FORM 4 wf-form4_167943965959717.xml 4 6033
  Complete submission text file 0001827672-23-000020.txt   7389
Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Issuer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 15440 LAGUNA CANYON ROAD, SUITE 160 IRVINE CA 92618
Business Address
Azamian Bobak R. (Reporting) CIK: 0001827672 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39614 | Film No.: 23750876